CA-BEATS-BY-DR-DRE
Beats by Dr. Dre (Beats) today announced a host of exceptional new wireless products, expanding the brand’s premium portfolio to include a new line of wireless earphones called BeatsX along with the next generation of two current best-sellers with the introduction of Powerbeats3 Wireless earphones and Beats Solo3 Wireless headphones. As a collection, these new products include the Apple W1 chip, Class 1 Bluetooth, Fast Fuel charge and the premium sound fans around the world have come to expect from Beats products. Beats was co-founded by Dr. Dre and Jimmy Iovine and is part of Apple.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160907006808/en/
"Beats has always been dedicated to delivering the best possible music listening experience,” said Beats President Luke Wood. “Now that almost everything we consume in media has a sound component, superior audio playback quality is key. With our new product, we are delivering great design, innovation and sound so that you can hear everything the way the content creators imagined.”
Beats X
BeatsX is an entirely new line of earphones, expertly designed to accommodate sophisticated audio advancements within its small form factor. Its simplistic, fluid design keeps BeatsX extremely light and nearly unnoticeable while wearing. Compatible with both iOS and Android devices, BeatsX features Class 1 Bluetooth for optimal connectivity. For iOS10 users, the Apple W1 chip provides an easy one-step Bluetooth connection and the added ability to toggle seamlessly between iCloud-registered devices. BeatsX sets a new standard for battery efficiency with Fast Fuel, which provides 2 hours of playback after just 5 minutes of charging and up to 8 hours after just 45 minutes of charging via the included Lightning cable. The RemoteTalk allows you to take calls, play music and activate Siri. The Flex-Form cable and variety of eartip and removable wingtip options provide a flexible, secure and comfortable fit during use. When you’re not using the earphones, magnetic ear buds keep them tangle-free around your neck, and they easily coil to fit into a compact carrying case for storage and portability.
Powerbeats 3 Wireless
Powerbeats3 Wireless truly takes one of the world’s best-selling wireless earphones to the next level. Improved ergonomics provide a better fit and sound experience, while Fast Fuel provides 1 hour of playback after just 5 minutes of charging via the included micro-USB cable. When fully charged, these sweat and water resistant earphones offer up to a 12-hour extended battery life. Additionally, the new Powerbeats3 Wireless earphones include integrated Class 1 Bluetooth and RemoteTalk, which allows you to take calls, play music and activate Siri.
Beats Solo 3 Wireless
Beats Solo3 Wireless is the next evolution of the already iconic Solo line of on-ear headphones. This new product provides up to 40 hours of battery life due to the efficiency of the Apple W1 chip, as well as Class 1 Bluetooth. The earcup controls let you take calls, play music and activate Siri, and Fast Fuel provides 3 hours of playback after just 5 minutes of charging via the included micro-USB cable. Beats Solo3 Wireless stays true to its predecessor with the same award-winning sound and portable, durable design featuring a flexible headband, 360-degree pivoting ear cups and noise isolation.
Visit Apple.com for pricing and availability. Additional assets for Beats X , Powerbeats 3 Wireless and Solo 3 Wireless available upon request.
About Beats
Beats by Dr. Dre (Beats) is a leading audio brand founded in 2006 by Dr. Dre and Jimmy Iovine. Through its family of premium consumer headphones, earphones and speakers, Beats has introduced an entirely new generation to the possibilities of premium sound entertainment. The brand’s continued success helps bring the energy, emotion and excitement of playback in the recording studio back to the listening experience for music lovers worldwide. Beats was acquired by Apple Inc. in July 2014.
Beats by Dr. Dre, Beats, Fast Fuel, Powerbeats, RemoteTalk and Solo are trademarks of Beats Electronics, LLC. Apple, Lightning and Siri are trademarks of Apple Inc. Other company and product names may be trademarks of their respective owners.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160907006808/en/
Contact:
Beats by Dr. Dre
Sarah Joyce, +1-310-795-4757
sarah_joyce@apple.com
or
Jessica
Bass, +1-310-895-6508
jessica_bass@apple.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom